Patent · US Active

Drug delivery system

US8999356B1 · kind B1 · utility

18Cited by

14References

15Claims

0Family size

Assignee

OMP, Inc. · US

Inventors

Jose E. Ramirez · Trumbull, US
Austin McNamara · Villa Park, US
Judy Hattendorf · Chino, US
Steve Goldner · Farmington Hills, US

Key dates

Filing date	Dec 1, 2005
Grant date	Apr 7, 2015
Priority date	—
Expiry date	Jul 2, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2800/884
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Drug delivery systems and a treatment regimen that improves percutaneous absorption of topically applied drug or active agent is described. The method generally has three steps including pre-treating the surface of skin in need thereof; applying an active ingredient to the skin; and applying a post treatment agent to the skin. Pre-treatment agents, drugs and active ingredients, as well as post treatment agents are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.